A pharmacist serves a customer. Cecilie_Arcurs/E+ via Getty Images Sizable dividend hikes can be telling about a company's overall tone toward its future and how much a company values its shareholders. All else equal, big dividend boosts convey a sense of optimism on the part of management and a commitment to rewarding shareholders. Elevance Health (NYSE:ELV) is a recent example of a company that I believe is trending in the right direction. The managed care giant just upped its quarterly dividend per share ...

Elevance Health, Inc. (ELV) reported fourth-quarter 2023 adjusted earnings of $5.62 per share, which surpassed the Zacks Consensus Estimate by 1.3%. The bottom line climbed 15.2% year over year.Operating revenues rose 7% year over year to almost $42.5 billion in the quarter under review. Also, the top line beat the consensus mark by 1.5%.The strong quarterly results benefited on the back of improved premiums in the Commercial Health Benefits business and better performance in the Carelon Services business. ...

Elevance Health, Inc. (NYSE:ELV) Q4 2023 Earnings Conference Call January 24, 2024 8:30 AM ET Company Participants Steve Tanal - VP of IR Gail Boudreaux - President and CEO Mark Kaye - CFO Peter Haytaian - President of Carelon Felicia Norwood - President, Government Health Benefits Business. Morgan Kendrick - President, Commercial Health Benefits Business Conference Call Participants A.J. Rice - UBS Kevin Fischbeck - Bank of America Josh Raskin - Nephron Research Sarah James - Cancer Fitzgerald Stephen Baxt ...

4Q 2023 Earnings Presentation • 2018 – 2023 adjusted diluted EPS CAGR of 16% exceeded the high end of our long-term target growth rate • Enhance the whole health of our members by serving as their lifetime, trusted health partner, especially through maximizing continuity of coverage for those subject to Medicaid redeterminations and adding key • We will continue to invest in high-growth opportunities to build upon our foundation for sustained, longterm growth • 4Q 2023 adjusted diluted EPS of $5.62 grew 15. ...

Elevance Health (ELV) came out with quarterly earnings of $5.62 per share, beating the Zacks Consensus Estimate of $5.55 per share. This compares to earnings of $5.23 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 1.26%. A quarter ago, it was expected that this health insurer would post earnings of $8.45 per share when it actually produced earnings of $8.99, delivering a surprise of 6.39%.Over the last four quarters, the comp ...

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2023 results. “We are pleased to have delivered another year of strong performance in 2023, enabled by our relentless focus on customer experience and affordability, and continued investments in growth and innovation. The balance and resilience of our business coupled with the focused execution of our enterprise strategy supports our confidence in our outlook for 2024, as we continue to optimize the found ...

Wall Street analysts forecast that Elevance Health (ELV) will report quarterly earnings of $5.55 per share in its upcoming release, pointing to a year-over-year increase of 6.1%. It is anticipated that revenues will amount to $41.82 billion, exhibiting an increase of 5.4% compared to the year-ago quarter.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course o ...

Elevance Health, Inc. (ELV) is set to report its fourth-quarter 2023 results on Jan 24, before the opening bell. This time around, the company’s overall earnings performance is likely to have received a boost from higher segmental profits, only to be undone by reduced total medical memberships and higher costs.What Do the Estimates Say?The Zacks Consensus Estimate for fourth-quarter earnings per share of $5.55 suggests a 6.1% increase from the prior-year figure of $5.23. The consensus mark remained stable o ...

Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and HealthEquity (HQY) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate re ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Elevance Health (ELV) been one of those stocks this year? A quick glance at the company's year-to-date performance in comparison to the rest of the Medical sector should help us answer this question.Elevance Health is a member of the Medical sector. This group includes 1077 individual stocks and currently holds a Zacks Sector Rank of #5. The Zacks Sector Rank considers ...